GMI現況

GMI小孢子靈芝免疫調節蛋白質結合多種創新技術,
己取得結構,檢驗與多種應用專利,同時持續累積發表學術文獻並取得多項國際認證。

GMI Certification
The Effect of Ganoderma Microsporum immunomodulatory proteins on alleviating PM 2.5-induced inflammatory responses in pregnant rats and fine particulate matter-induced neurological damage in the offsprings 2021-11-15

Abstract

Fine particulate matter 2.5 (PM2.5) induces free radicals and oxidative stress in animals, leading to a range of illnesses. In this study, Ganoderma Microsporum immunomodulatory (GMI) proteins were administered to alleviate PM2.5-induced inflammatory responses in mother rats, and PM2.5-induced inflammatory responses and neurological damage in their offspring. The results suggested that GMI administration decreased the risk of neurological disorders in mother rats and their offspring by reducing the white blood cell count, lessening inflammatory responses and PM2.5-induced memory impairment, and preventing dendritic branches in the hippocampi from declining and microRNAs from PM2.5-induced modulation.

 

資料來源:https://www.nature.com/articles/s41598-019-38810-5

參考資料:靈芝蛋白GMI能預防 PM2.5對懷孕母鼠與胎鼠的毒害,有效維護兩代的健康

聯絡我們
聯絡位置

222 新北市深坑區北深路三段270巷12號8樓之1

聯絡電話

+886-2-2662-0148